Fda

NOW offers roadmap to help consumers navigate supplements

NOW offers roadmap to help consumers confidently navigate supplements

By Claudia Adrien

Seventy-four percent of U.S. adults take dietary supplements, according to the 2023 CRN Consumer Survey on Dietary Supplements. That does not mean that they are always equipped with the tools to navigate the myriad of products available or are confident...

© Parradee Kietsirikul / Getty Images

UNPA's reflections on 2023: The year of opposite choices

By Loren Israelsen, Founder & President, United Natural Products Alliance (UNPA)

My reflection on 2023 has little to do with specifics. In my view, this was a year of opposite choices and opposing directions – the big stuff. Yet, daily demands to address the urgent (but often not so important) dulled our senses and intuition. Hence,...

FDA & Pharmavite join speaker roster for the DSHEA Summit

FDA & Pharmavite join speaker roster for the DSHEA Summit

By Stephen Daniells

Dr Cara Welch, Director of FDA’s Office of Dietary Supplements Programs, and Christine Burdick-Bell, EVP & General Counsel at Pharmavite, have confirmed their participation in the NutraIngredients-USA’s landmark DSHEA Summit.

© Edalin / Getty Images

FDA delays response to Nammex’s Mushroom product labeling petition

By Stephen Daniells

The US Food and Drug Administration has declined to respond to a Citizen Petition by North American Reishi Ltd (“Nammex”) on the labeling and sale of food and supplements containing fungal ingredients, citing “competing agency priorities”.

© erdemerdemli / Getty Images

Guest Article

Apple Picking and Drug Preclusion: Let’s Make it a Fair Contest

By Steve Mister, President & CEO, Council for Responsible Nutrition

In this guest article, Steve Mister, President & CEO, Council for Responsible Nutrition, discusses how “surgical amendments to the existing drug preclusion provision” can balance the interests of drugs and supplements and allow innovation in both...

CRN’s Mister on FDA reorg, FTC petition, and state of the market

CRN’s Mister on FDA reorg, FTC petition, and state of the market

By Stephen Daniells

Recent statements and conversations with senior officials at the FDA have revealed “an apparent knowledge gap within the upper echelons of the Agency” regarding the regulation of dietary supplements, says Steve Mister, President and CEO of the Council...

NPA’s Fabricant on NMN, 25-(OH)D, NDIs, and more

NPA’s Fabricant on NMN, 25-(OH)D, NDIs, and more

By Stephen Daniells

While uncertainty continues around NMN, FDA should make it clear to commercial platforms that they haven’t made a final decision on the ingredient and that it should be still available to consumers, says Daniel Fabricant, President & CEO of the Natural...

Image courtesy of CRN

Califf and Mister talk: Top 6 takeaways

By Danielle Masterson

Making several references to sports, Califf talked transparency, innovation, MPLs, CBD and more. But did he drop the ball or knock it out of the park?

Gaia Herbs extends open invite to FDA

Gaia Herbs invites FDA to come visit ‘any time at all’

By Asia Sherman

As part of a new campaign to showcase responsible and rigorous practices in the dietary supplement industry, Gaia Herbs has extended an open invitation to the Food and Drug Administration (FDA) to inspect its operations.

© zhudifeng / Getty Images

NPA submits Citizen Petition on labeling of mushrooms & mycelia

By Stephen Daniells

The Natural Products Association (NPA) is seeking clarity on the labeling of fungi ingredients in dietary supplements, with a Citizen Petition requesting FDA to incorporate aspects of guidance from the American Herbal Products Association (AHPA).

Getty Images / 24K-Production

Pressure mounts on FDA to regulate CBD

By Danielle Masterson

Lawmakers and stakeholders assembled for a congressional hearing on July 27 to highlight how FDA’s refusal to regulate CBD is threatening consumer access to safe products.

Getty Images / Youngvet

All eyes on Dietary Supplement Master Files

By Danielle Masterson

Fresh off a new Draft Guidance release, many are hopeful that Master Files would provide clarity on NDI filing requirements and provide protections for intellectual property. However, some point to issues with the NDI framework and say that must be solved...

NPA’s Fabricant on FDA reorg, HSAs/FSAs, Master Files, NMN and more

NPA’s Fabricant on FDA reorg, HSAs/FSAs, Master Files, NMN and more

By Stephen Daniells

From a proposed reorganization of the Food & Drug Administration to progress (or not) on the NMN situation, there’s a lot going on in the dietary supplements industry. We caught up with Daniel Fabricant, PhD, president and CEO of the Natural Products...

Fungi Perfecti responds to ‘puzzling opinion’ in Nammex petition

Fungi Perfecti responds to ‘puzzling opinion’ in Nammex petition

By Asia Sherman

Fungi Perfecti, a supplier of mycelium-based supplements, has written an open letter to address the citizen petition filed by mushroom extract company Nammex, which requested that the Food and Drug Administration act to ensure proper labeling of fungi...

© PromesaArtStudio / Getty Images

Guest Article

Ex-Health Canada NHP DG: ‘Cannabis is Canada’s New Wild West’

By Adam Gibson, President, True Moderation

When it comes to regulating CBD and cannabis, Canada is an extreme cautionary tale for the US, says Adam Gibson, the former Director General of Health Canada’s Non-prescription and Natural Health Products Directorate.

FDA: SARMs not worth the health risk ‘for a few extra likes’

FDA: SARMs not worth the health risk ‘for a few extra likes’

By Asia Sherman

The U.S. Food and Drug Administration (FDA) issued an advisory this week warning of adverse event reports related to selective androgen receptor modulators (SARMs). In the letter, the agency also takes issue with online vendors and social media influencers...

ODSP’s director on NDIs, MPL, and NMN

ODSP’s director on NDIs, MPL, and NMN

By Danielle Masterson

NutraIngredients-USA caught up with Cara Welch, PhD, Director of FDA's Office of Dietary Supplement Programs. Welch talked inspections, made the case for MPL and hinted NDI guidance is on the way.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All